'Copies' of Ozempic are sold for $14: India launches generics of semaglutide after patent expiration
India has introduced generic versions of semaglutide, the active ingredient in Ozempic, at a lower price following the expiration of its patent.
India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires
Indian drug manufacturers are set to launch generic versions of Ozempic for just $14 a month following the expiration of Novo Nordisk's patent.
Weight Loss Will Reduce by ₹3000! Weight Loss Injections Becoming 70% Cheaper
The patent expiration of the weight loss drug Semaglutide on March 20 will lead to a significant price drop of up to 70% for consumers in India.
The patent for Ozempic expired, revealing an interesting fact about the price of its copy in Argentina
The expiration of the Ozempic patent will lead to a significant decrease in prices as generic versions from Indian pharmaceutical companies enter the market, but Argentine copies remain notably expensive.
Ozempic is about to become generic for billions of people
Ozempic will soon be available as a generic drug in many populous countries, significantly lowering its price and improving accessibility.
A. Grzegorzewska, Gedeon Richter: Asian business enters the European drug market
Aneta Grzegorzewska discusses the aggressive strategy of Indian pharmaceutical companies entering the European market with generic products.
A. Grzegorzewska, Gedeon Richter: Asian Business Enters the European Drug Market
The article discusses the aggressive strategy of Indian companies seeking to enter the European generic drug market as Europe aims for greater autonomy in pharmaceuticals.
India to tackle global obesity with cheap fat-loss jabs
India is set to release low-cost generic weight-loss injections following the expiration of key patents, which is expected to make such treatments more accessible globally.
Cheaper copies of Ozempic will soon flood the market. India's patent expires on Friday
India is set to see the expiration of a patent for the diabetes drug Ozempic, paving the way for cheaper alternatives to enter the market.
Ozempic and Wegovy: India's cheap weight-loss pens that could change the global battle against obesity
India is expected to reduce obesity rates significantly with the impending expiration of the semaglutide patent, allowing for cheaper generic versions of popular weight-loss drugs.
The H-hour for obesity drugs is Friday
The patent for the obesity treatment drug semaglutide will expire in India on Friday, leading to potential price reductions and increased market competition.
Ozempic and Wegovy: The Cheap Weight Loss Pens from India That Could Change the Global Fight Against Obesity
India is poised to significantly lower obesity rates with the upcoming expiration of the semaglutide patent, allowing local pharmaceutical companies to produce cheaper generic versions of Ozempic and Wegovy.
The Ozempic patent falls in the largest countries, prices drop, and previously unknown data comes to light
The expiration of the Ozempic patent in populous countries like India and China paves the way for cheaper generic versions of GLP-1 medications, significantly impacting global health.
Ozempic: With the expiration of the patent will prices fall? Will we have a generic version? See what to expect now
The patent on semaglutide, the active ingredient in Ozempic, expires in Brazil, possibly leading to lower prices and generic versions of the drug in the future.
Jan Aushadhi Kendra: You can start a business by opening a Jan Aushadhi Center, and the government is providing financial assistance of up to 200,000 rupees
The Indian government is promoting the establishment of Jan Aushadhi Kendra, offering financial assistance to those looking to start a business selling affordable generic medicines.
EMS plans to launch a generic version of Ozempic by September
Brazilian pharmaceutical EMS aims to introduce its generic version of Ozempic to the market by September, contingent on the approval from health agency Anvisa within the next 60 days.
South Africa: Bringing It Home - South Africa is Leading the Charge to Make Anti-HIV jab for Africa
South Africa's National Aids Council is soliciting local drug companies to apply for the creation of generic versions of the anti-HIV jab lenacapavir, targeting a goal to end AIDS in the country by 2043.
'Hoppers' Review: Jon Hamm, Meryl Streep elevate Pixar's run-of-the-mill beaver adventure
A review of Pixar's latest film 'Hoppers' highlights its generic plot and indicates that the studio is playing it safe by relying on predictable themes and characters.
EMS agrees to buy Medley, a brand of generic drugs from Sanofi
The EMS Group has agreed to acquire 100% of Medley, a leading generic drug brand in Brazil, from the French pharmaceutical company Sanofi.
EMS announces purchase of Medley and forms pharmaceutical giant
The pharmaceutical group EMS has secured an agreement with French company Sanofi to purchase 100% of Medley, one of Brazil's leading generic brands.
The generic drug market is changing the dynamics
Significant changes in the generic drug market are set to transform its dynamics by 2026, with major mergers and acquisitions already altering the sector.
By just one vote, Rio Preto City Council rejects bill to revoke the Generic Value Map of properties
The City Council of São José do Rio Preto narrowly rejected a bill proposing the revocation of the Generic Value Map of properties by a single vote, sparking unrest among residents.
Correction: decree that alters the Generic Value Plant in Rio Preto
G1 corrected a previously published error regarding a decree related to property valuations in São José do Rio Preto, Brazil.
City Hall of Rio Preto revokes decree that altered the Generic Plan for properties
The city government of São José do Rio Preto has revoked a decree that proposed changes to the city's property valuation plan due to concerns about inflated assessments.
'Late Fees', 'Temporary Additions', 'Other': Generic Terms Camouflage Extras in Magistrate Salaries
The article discusses how Brazilian magistrates receive additional payments above the constitutional ceiling, described with vague terms, including amounts paid even after mandatory retirement due to penalties for serious offenses.
Pharmaceutical company Dr. Reddy's prepares to launch a cheap generic Ozempic in India in March
Indian pharmaceutical company Dr. Reddy’s Laboratories is set to launch a generic version of the diabetes drug Ozempic, named Obeda, in March 2026 following the expiration of the semaglutide patent.
Poland focuses on small reactors. Agreement signed in the USA
Poland's Ministry of Energy has signed an agreement to develop a generic design for SMR reactors, which are projected to be key in Poland's nuclear energy strategy.
End of Ozempic patent could reduce price by up to 35%, says laboratory wanting to make generic
The expiration of the semaglutide patent in March is expected to lead to a price reduction of up to 35% for Ozempic, according to pharmaceutical company EMS, which is interested in producing a generic version.
Radio News (25.02.2026 12:00:00)
This is a generic radio news announcement without specific content provided.
Analysis: Beginner Investor: With These Four Advantages, You Will Succeed
The article provides investment tips tailored for young, beginner investors, emphasizing personalized strategies over generic advice.
Children on the criticized AI series: "Terrible"
Children have voiced harsh criticisms of SVT's AI-animated children's programs, labeling them as 'terrible' and 'generic.'
The patent for the most expensive diabetes drug has been revoked. Are cheaper alternatives closer to reimbursement?
A patent for dapagliflozin, a leading diabetes medication, has been revoked, potentially paving the way for cheaper generic versions to be reimbursed in Poland.
India: Generic versions of Ozempic and Wegony Coming – They Will Be 60% Cheaper
An Indian pharmaceutical company is set to launch generic versions of obesity drugs Ozempic and Wegony at significantly reduced prices in India.
What do we know about Farmacias Similares' expansion to Japan?
Farmacias Similares, the largest pharmacy chain in Latin America, is expanding into Japan using a digital marketing model and local adaptations to its brand.
Doctor Simi in Japan?
Farmacias Similares, led by Víctor González Herrera, is expanding its reach to Japan using digital marketing strategies and local adaptation.
She is chillingly good in the heartwarming production
A review of the Disney musical 'Frozen' highlights its impressive performances but also notes its generic nature.
The Dangers of Drug Price Cuts Based on Fiscal Logic
The South Korean government's policy to reduce drug prices raises concerns about its potential negative impact on public health and the domestic pharmaceutical industry's sustainability.
Are Generic Drugs Cut to Create New Drugs? … It’s a Misdiagnosis
The ongoing debate surrounding the Ministry of Health and Welfare's proposal to lower the prices of generic drugs in South Korea has raised concerns about its implications for new drug development and the pharmaceutical industry.
City hall announces decrease in the assessed value of 14,000 properties in Rio Preto after Fipe reviews the generic valuation plan used as the basis for IPTU calculation
The city of São José do Rio Preto has announced a decrease in the assessed value of 14,000 properties following a review of the property valuation plan by Fipe, which impacts the municipal property tax (IPTU).
Novo Nordisk Stock Rises After Cancellation of Copy Pill
Novo Nordisk's stock rose significantly after Hims and Hers announced they would not sell a generic version of Wegovy.
City Hall requests a specific review of the generic valuation used as the base calculation for the IPTU in Rio Preto
The City Hall of São José do Rio Preto (SP) has requested Fipe to conduct a specific review of the Generic Valuation Plan used as the base calculation for the 2026 Property Tax (IPTU).
A generic Ozempic for 15 euros per month or how to revolutionize the obesity drug market
The expiration of Novo Nordisk's patent in some countries pressures the Danish pharmaceutical company as its diabetes injection Ozempic becomes synonymous with weight loss globally.
Europe Gets Hooked on Chinese Drugs: Journey to the Starting Point of the New Silk Road of Medications
The city of Suzhou, known for its ancient canals and cultural significance, is now the heart of China's pharmaceutical industry, producing active ingredients and generic drugs for markets worldwide.
US Patent Office denies A’s trademark applications for ‘Las Vegas Athletics’
The U.S. Patent and Trademark Office rejected the Oakland Athletics' requests to trademark 'Las Vegas Athletics' and 'Vegas Athletics' due to the generic nature of the term 'Athletics' and potential confusion with other activities.
The Patents for Weight Loss Drugs Expire: Generics Are Coming
The expiration of patents for weight loss drugs is paving the way for the introduction of generic alternatives in the global obesity medication market.